The evidence consistently points in one direction: nocturnal blood pressure is a stronger risk factor for cardiovascular disease than a daytime measurement. The studies are observational in nature, however, so cause and effect cannot be established with certainty. In practical terms, this means that a 24-hour measurement or sleep recording provides more information than a blood pressure reading at the doctor's office alone, and that the timing of blood pressure-lowering medication is worth discussing with a doctor.
Nocturnal blood pressure turns out to be a stronger predictor of cardiovascular disease than a daytime measurement at the doctor's office. The 2025 European Hypertension Guidelines recognise nocturnal blood pressure as an independent risk factor, separate from daytime values. This means that someone with a 'normal' blood pressure at the practice may still have an elevated risk if their blood pressure does not drop sufficiently during the night.
Particularly striking is the risk posed by high blood pressure in the lying position, even when blood pressure measured while sitting is normal. In a large study of more than 11,000 people followed for 25 to 28 years, elevated blood pressure in the lying position was associated with a 60% greater chance of a heart attack, an 83% greater chance of heart failure, an 86% greater chance of a stroke, and 43% more deaths from all causes. People with only elevated blood pressure while lying down had a comparable risk to people whose sitting blood pressure was also elevated. This suggests that measuring blood pressure while a person is lying down provides more information than is generally assumed.
Under normal circumstances, blood pressure drops by 10 to 20 percent during the night, a so-called 'dipping' pattern. When that drop is absent (non-dipping), the risk of cardiovascular disease increases. The most dangerous pattern is the so-called riser pattern, in which blood pressure is actually higher at night than during the day. In the Japanese JAMP study of 6,359 patients, that pattern was linked to 48% more cardiovascular events and a more than twofold higher risk of heart failure compared with people who had a normal day-night rhythm. For every 20 mmHg increase in nocturnal systolic blood pressure, the risk of heart failure rose by 25%.
Sleep apnoea is an important cause of nocturnal blood pressure problems. Repeated episodes of oxygen deficiency activate the sympathetic nervous system and cause blood pressure spikes that increase the risk of coronary artery disease, heart failure, stroke, and cardiac arrhythmias. Treatment with CPAP, a mask that keeps the airway open, does lower difficult-to-treat high blood pressure, but in randomised trials it has not yet produced a proven reduction in hard cardiovascular outcomes. Non-dipping is also more common in people with kidney problems, diabetes, or disorders of the autonomic nervous system.
Whether taking blood pressure-lowering medication before bedtime rather than in the morning is beneficial is an active area of research. The MAPEC study, involving 2,156 patients over an average of 5.6 years, showed impressive results: 61% fewer cardiovascular events and 67% fewer serious complications with evening intake, and the non-dipping pattern also improved. Nevertheless, the 2025 European Hypertension Guidelines state that findings across different studies are not consistent. Multiple studies confirm that evening intake improves the nocturnal blood pressure profile, but whether this also consistently leads to fewer heart attacks and strokes has not yet been definitively established. Anyone at risk of nocturnal hypertension would do well to discuss this with their doctor, because depending on the medication and the individual situation, the timing of intake can indeed make a difference.
The claims are based on observational studies (including the JAMP study, an American cohort of 11,000+ participants, and the MAPEC study), the ESH Guidelines 2025, and randomised trials on CPAP and chronotherapy. All associations are observational in nature; only for chronotherapy is there some indication of causality, but even there the evidence is not fully consistent. PMIDs used: 40509714, 33131317, 39841470, 34353537, 39242062, 20854139, 32639886, 20000139.